2019 New England Venture Summit
Leslie-Anne Maxwell, Partner and Chair of Cantor Colburn's Pharmaceutical Patent Practice will attend the 2019 New England Venture Summit on December 4th, 2019 at the Hilton, Boston Dedham. Where Innovation Meets Capital™, this conference will showcase top innovators from companies like Philips, Schlumberger, SABIC, Dow, DuPont and Boehringer Ingelheim sharing the stage with venture capitalists discussing topics and trends in the financial markets and the future of venture capital investment in clean-tech. Ed-tech Investors will take center stage to grade the Ed-tech sector and share insights on the trends they’re seeing.
Anne received her Ph.D. in Biophysical Chemistry as well as her M.S in Chemistry from Yale University. She provides all aspects of patent representation to clients working in chemical and life science research with a particular emphasis on the pharmaceutical and agricultural chemical industries, and Chairs the firm's Pharmaceutical Patent Practice. Anne has more than 15 years’ experience drafting patent applications and prosecuting U.S. and non-U.S. patent applications in the areas of small molecule pharmaceuticals, drug delivery and formulations, biological therapeutics, chemical processes, medical diagnostics, biomaterials, and agricultural chemicals. Anne performs searches, determines patentability and freedom to operate, drafts and prosecutes patent applications, counsels clients in their development of effective patent protection worldwide, and assists clients with licensing and due diligence. Anne also prepares invalidity and non-infringement opinions and supports Cantor Colburn’s Litigation Department in Abbreviated New Drug Application litigation. Prior to joining Cantor Colburn, Anne worked as a patent agent and chemist at a biotechnology company.